23andMe Holding Co. provided earnings guidance for the fiscal year ending March 31, 2023. For the year, company expects revenue to be in the range of $260 million to $280 million, with a net loss in the range of $350 million to $370 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5453 USD | -2.31% | +6.28% | -40.31% |
May. 23 | Earnings Flash (ME) 23ANDME Reports Q4 Revenue $64M, vs. Street Est of $61.5M | MT |
May. 23 | 23andMe Q4 Loss Widens, Revenue Decreases | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.31% | 267M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
+2.72% | 2.63B | |
-2.98% | 2.64B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- ME Stock
- News 23andMe Holding Co.
- 23andMe Holding Co. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023